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ABSTRACT
Aim: Pain is the second most frequent persistent symptom following cancer treatment. This article aims
at explaining how the implementation of contemporary pain neuroscience can benefit rehabilitation for
adults following cancer treatment within an evidence-based perspective.
Materials and methods: Narrative review.
Results: First, pain education is an effective but underused strategy for treating cancer related pain.
Second, our neuro-immunological understanding of how stress can influence pain highlights the import-
ance of integrating stress management into the rehabilitation approach for patients having cancer-related
pain. The latter is supported by studies that have examined the effectiveness of various stress manage-
ment programmes in this population. Third, poor sleep is common and linked to pain in patients follow-
ing cancer treatment. Sleep deprivation results in a low-grade inflammatory response and consequent
increased sensitivity to pain. Cognitive behavioural therapy for sleep difficulties, stress management and
exercise therapy improves sleep in patients following cancer treatment. Finally, exercise therapy is effect-
ive for decreasing pain in patients following cancer treatment, and may even decrease pain-related side
effects of hormone treatments commonly used in cancer survivors.
Conclusions: Neuro-immunology has increased our understanding of pain and can benefit conservative
pain treatment for adults following cancer treatment.
 IMPLICATIONS FOR REHABILITATION
 Pain education is effective for improving cancer pain; implementation of contemporary pain neurosci-
ence into the educational programme seems warranted.
 Various types of stress management are effective for treating patients following cancer treatment.
 Poor sleep is common in patients following cancer treatment, and rehabilitation specialists can
address this by providing exercise therapy, sleep hygiene, and/or cognitive behavioural therapy.
 Exercise therapy is effective for decreasing pain in patients following cancer treatment, including the
treatment of pain as a common side effect of hormone treatments for breast cancer survivors.
ARTICLE HISTORY
Received 7 July 2016
Revised 8 November 2016
Accepted 13 November 2016
KEYWORDS
Pain; neuropathic;
sensitization; exercise;
education; sleep
Introduction
Life expectancy for people following cancer treatment has
increased due to the early detection and advances in cancer treat-
ment.[1,2] Unfortunately, cancer survivors often face long-term
symptoms that arise or persist beyond the completion of treat-
ment, making it an increasingly important population for the field
of rehabilitation. In addition to fatigue, pain is the most frequent
persistent symptom following cancer, and cancer treatment.[3]
The high prevalence of pain in the growing cancer survivor popu-
lation is of considerable concern due to the fact that pain is asso-
ciated with reduced quality of life and day-to-day
functioning.[4–8]
Modern pain neuroscience and neuro-immunology has
advanced our understanding about pain. Early paradigms of pain
being proportional to injury, i.e., nociceptive input have evolved
over the decades to include Wall and Melzack’s gate control the-
ory,[9] with more recent insights on the role of nervous system
sensitization [10] (defined as “an amplification of neural signaling
within the central nervous system that elicits pain hyper-
sensitivity”,[11]), and the complex interactions between nocicep-
tive pathways and the immune system, i.e., neuro-
immunology.[12,13] Pain neuroscience has evolved, and rehabilita-
tion clinicians around the globe are at the front line for imple-
menting contemporary pain neuroscience in clinical practice.
Implementation of pain neuroscience in clinical practice has
gained wide attention in the area of musculoskeletal physiother-
apy, but not so much in other areas like oncology. Therefore, here
we explain how implementation of contemporary pain
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neuroscience and neuro-immunology can benefit conservative
treatment for people having pain following cancer (treatment).
The first part of the article provides an update of our current
understanding of pain following cancer (treatment). The next part
explores new pain treatment strategies within an evidence-based
perspective.
Pain in patients following cancer (treatment)
Pain in patients following cancer (treatment) is often neuropathic
in nature;[14] mainly peripheral neuropathic pain. Cancer-related
neuropathic pain syndromes may be subdivided into (1) cancer-
related neuropathic pain, (2) cancer-therapy-induced neuropathic
pain, and (3) cancer-associated neuropathic pain. Examples of the
first are paraneoplastic neurological syndromes and tumour/
metastasis infiltration or compression of the central, and/or per-
ipheral nervous system,[15] however, further detail is beyond the
scope of this article. Neuropathic pain is often a side effect or
complication of various life-preserving treatments for cancer
[16–18] like surgery.[16,17] Post-mastectomy pain syndrome
[19–21] is a common example of cancer-therapy-induced neuro-
pathic pain which often relates to damage to the long thoracic or
thoracodorsal nerve, intercostobrachial nerve [22] or due to a
neuroma. In cancer survivors with a history of thoracotomy, inter-
costal nerve injury is a common type of cancer-therapy-induced
neuropathic pain, possibly explaining chronic chest wall pain.[21]
In addition to surgery, other cancer-therapy-induced neuro-
pathic pain syndromes like radiation therapy may also affect sur-
rounding structures including nerves and neural plexi (e.g., the
lumbosacral plexus during irradiation of pelvic organs.[17]). The
prevalence of radiation-induced neuropathy has decreased sub-
stantially over the past 70 years.[23] However, radiation-induced
peripheral neuropathy usually appears several years after radio-
therapy,[23] which makes it still prevalent these days. Finally, due
to chemo-toxicity, chemotherapy is a third common cause of
neuropathy in patients following cancer treatment.[21,23] Clinical
signs include sensory signs (numbness and burning feeling) rather
than pain per se; pain can be present but is reported less com-
monly.[21] Neuropathies related to treatment are most common
and are thus mainly due to damage at the peripheral nerve sys-
tem, resulting in complaints localized in the respective regions.
Post-herpetic neuralgia is the most common example of can-
cer-associated neuropathic pain, and is developed by approxi-
mately 25–50% of cancer patients following an acute herpes
zoster infection. Indeed, because of the higher incidence of
immunosuppression in cancer patients, acute herpes zoster is
more likely to occur in cancer patients than in the general
population.[24]
In addition to neuropathic pain, nociceptive pain is also pos-
sible in patients following cancer treatment. Common sources of
nociception in these patients include connective tissue fibro-
sis,[25–27] skeletal-related events,[28] oedema,[29] rashes, ulcers,
myofascial pain, and movement dysfunctions, e.g., scapular dyski-
nesis.[30] Finally, emerging evidence suggests a role for central
sensitization in explaining pain in a subgroup of cancer survi-
vors.[31–33] These studies revealed widespread pressure pain
hypersensitivity in people treated for breast or colon can-
cer.[31–33] However, some studies found only local hypersensitiv-
ity [33,34] and studies investigating other features of central
sensitization pain (peripherally driven central excitability and dys-
functional endogenous analgesia) are inconclusive.[35–37]
Together these findings suggest that pain following cancer treat-
ment is not always dominated by central sensitization, but instead
may be present in a subgroup. Moreover, pain following cancer
(treatment) is likely a mixed pain condition. Guidelines for identi-
fying the relevant or even dominant type of pain in patients fol-
lowing cancer treatment have been proposed.[38]
Traditionally, rehabilitation clinicians have been involved in
optimizing muscle and joint function in patients following cancer
treatment. This includes restoring upper limb function in patients
following breast cancer surgery.[39] However, rehabilitation clini-
cians can do much more than providing hands-on treatment for
improving joint function in adults following cancer treatment. The
next sections explore the treatment options for implementing
contemporary pain neuroscience and neuro-immunology within
evidence-based treatment for adults suffering from pain following
cancer treatment.
Educating patients following cancer treatment about
their pain
A meta-analysis of 21 trials concluded that patient-based educa-
tional interventions are effective but underused for treating cancer
related pain.[40] Equivocal evidence was found for a positive
effect on pain severity, knowledge, and self-efficacy,[40] each of
which are crucial for preparing patients for subsequent phases of
the rehabilitation programme. It is notable that the positive
effects noted in this review were modest, thus integration with
other aspects of pain management appears appropriate.
Moreover, the content of the included education is variable and
poorly established, as highlighted in the meta-analysis of Bennett
et al..[40] Up to now, most of the educational interventions for
cancer patients have been restricted to more biomedical pain
management instructions (e.g., use of analgesics).[40]
When providing education to patients following cancer treat-
ment, implementation of contemporary pain neuroscience into
the educational programme seems warranted (Table 1 provides
key messages). Pain neuroscience education includes explaining
to patients that pain is an output product of the brain resulting
from input from multiple central and peripheral nervous system
processes, and leading to the perception of threat rather than
pain being a reflection of current tissue damage.[41] Pain neuro-
science education intends to transfer that knowledge to patients,
allowing them to understand their pain and hence to effectively
cope with their pain.[41] This includes explaining to patients that
the pain is the sum of many processes within the nervous system
and brain, which may or may not include nociception, and thus
frequently poorly reflects current tissue damage. In non-cancer
population with pain, pain neuroscience education is welcomed
Table 1. Key messages.
1. Pain is often ignored in the field of oncology, but pain is very com-
mon, and debilitating in cancer survivors.
2. Implementation of pain neuroscience in rehabilitation practice has
gained little attention in the field of oncology.
3. Pain education is effective for improving cancer pain; implementation
of contemporary pain neuroscience into the educational pro-
gramme seems warranted.
4. The dysfunctional stress response as seen in some patients following
cancer treatment may relate to pain (increases), provides a theor-
etical basis for implementing stress management into the treat-
ment of pain in this population.
5. Various types of stress management are effective for treating patients
following cancer treatment.
6. Poor sleep is common in patients following cancer treatment, and
rehabilitation specialists can address this by providing exercise
therapy, sleep hygiene, and/or cognitive behavioural therapy.
7. Exercise therapy is effective for decreasing pain in patients following
cancer treatment, including the treatment of pain as a common
side effect of hormone treatments for breast cancer survivors.
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very positively by patients, [42,43] and is effective in changing
pain beliefs, and improving health status as well as pain coping
strategies.[42–50] However, studies examining the effectiveness of
pain neuroscience education in patients following cancer treat-
ment are lacking and are, therefore, an important research priority
(Table 2 provides a research agenda).
According to the meta-analysis mentioned previously, educa-
tion for cancer related pain did not result in positive effects on
interference with daily activities,[40] indicating that education can
be a first, and important step but requires follow-up with more
active interventions including stress management as well as exer-
cise, and functional activity interventions.
Stress management
Some people will show blunted cortisol responses to psycho-
logical stress,[51,52] flatter diurnal cortisol rhythms,[53] and lower
heart rate variability [54,55] following cancer treatment. These
findings are suggestive of a subtle hypothalamus-pituitary adrenal
axis dysfunction and decreased vagal activity in these patients.
How does this relate to pain?
Several potential mechanisms included in our current under-
standing of cancer pathophysiology [56,57] (e.g., oxidative stress
and the role of inflammation), explain why decreased vagal activ-
ity may contribute to pain.[58] Low-vagal nerve activity implies
less inhibition of inflammation (including oxidative stress), higher
sympathetic activity, and low activity in brain regions capable of
modulating nociceptive input,[58] thereby explaining in part how
the pain experience may be magnified in the presence of stress.
In addition, the stress response system is capable of influenc-
ing nociceptive processing through various pathways.[59–65] In
addition to its anti-inflammatory effects, cortisol (“the” stress hor-
mone) holds analgesic effects as well: e.g., the dorsal horn gluco-
corticoid receptors have analgesic capacities.[65] Second, in
primary afferent nociceptors, stress triggers a switch in second
messenger signalling for pro-nociceptive immune mediators, pos-
sibly explaining stress-induced symptom flares.[59] Stress activates
the dorsomedial nucleus of the hypothalamus and subsequent
activation of ON-cells (neurons increasing pain) plus suppression
of OFF-cells (neurons decreasing pain).[64] Finally, chronic stress
has detrimental effects on gamma-amino-butyric acid (GABA)-
neurotransmission both at the spinal and supraspinal level, result-
ing in generalized hyperalgesia, and disinhibition of the hypothal-
amic-pituitary-adrenal axis.[63] Together these neuro-immune
reactions can result in stress-induced hyperalgesia (augmented
nociceptive facilitation and suppressed nociceptive inhibition)
rather than stress-induced hypoalgesia.[64]
Our neuro-immunological understanding of how stress can
influence pain highlights the importance of examining whether
dysfunctional stress mechanisms demonstrated by patients follow-
ing cancer treatment [51–55] account for (in part) or contribute to
the individual’s pain. Therefore, it seems warranted to integrate
stress management into the management of pain following cancer
treatment. Stress management is an evidence-based intervention
for patients following cancer treatment. In breast cancer popula-
tions, there is some evidence to support the use of cognitive
behavioural stress management.[66] Also, a stress management
intervention comprising relaxation, cognitive restructuring, and
coping skills training was found to be effective in patients follow-
ing surgical breast cancer treatment,[67] while mindfulness-based
stress reduction has been shown to be effective in general cancer
populations.[68,69]
In clinical practice, engaging patients in such stress manage-
ment programs is often a challenge – use of stress management
skills sometimes contradicts patients’ illness beliefs. Explaining to
patients that stress is closely related to their (exacerbation of)
symptoms is often misinterpreted as “it’s all in my mind.” One
way to overcome this is by integrating the above outlined neuro-
immunology behind stress and pain to show that the stress
response system is “real” (i.e., holds a biological nature) and that
it involves part of the central nervous system (e.g., the autonomic
branch of the central nervous system) and complex endocrine
axes (including the hypothalamic-pituitary-adrenal axis). Stress
management should incorporate acknowledgement that inherent
stress response systems may not be functioning properly, and
that external assistance is required in order to cope better with
everyday stressors. If the illness perception regarding the role of
stress is adopted properly, and if the patient can see how the
approaches outlined can assist or strengthen the stress response
system, then improved adherence with stress self-management
interventions might be achievable.
The inability to cope with everyday stressors is a frequent
cause of sleeping difficulties.[70,71] Conversely, effective stress
management improves sleep.[72,73] How this applies to (pain in)
the cancer survivor population will be addressed in the next
section.
Sleep self-management
Poor sleep is common in patients following cancer treatment
[74,75] even in adult survivors of childhood cancer.[76,77] This
illustrates that sleep difficulties, when left untreated, do not
always naturally resolve in this population. Poor sleep in patients
following cancer treatment is accompanied with poor physical
health and anxiety.[76,77]
Poor sleep has been linked to pain in the cancer [74] (survivor
[78]) population and is associated with headache in cancer survi-
vors.[76] Our current understanding of sleep neuro-immunology
provides potential links between sleep difficulties and (the onset
of) pain. While proper sleep facilitates immune health, sleep
deprivation results in low-grade inflammatory responses.[79–81]
This low-grade inflammatory response as a consequence of sleep
deprivation includes increased levels of interleukin 6, prostaglan-
din E2,[80,81] and nitric oxide [82] possibly mediated by cerebral
microglia.[82] Even low levels of inflammatory cytokines are
known to affect brain function,[83] which correlates with observa-
tions of increased sensitivity to painful stimuli following sleep
restriction.[80,84,85] Taken together, sleep deprivation imparts a
low-grade inflammatory response leading towards increased sensi-
tivity to pain as typically seen in chronic pain sufferers. Our
neuro-immunologic understanding of the link between sleep and
Table 2. Research agenda.
Hypotheses
1. Pain neuroscience education is more effective than standard pain edu-
cation for decreasing pain, and improving pain cognitions/beliefs in
patients following cancer treatment.
2. The dysfunctional stress response as seen in some patients following
cancer treatment relates to pain (increases) and the hyperexcitability
of the central nervous system.
3. Stress management is effective for decreasing pain and the hyperexcit-
ability of the central nervous system in patients following cancer
treatment.
4. Specific conservative treatment for improving sleep in cancer survivors
will not only result in sleep improvements, but also in decreased
hyperexcitability of the central nervous system and decreased pain
severity.
5. Exercise therapy is effective in improving endogenous analgesia, and
the physiological stress response systems in patients following can-
cer treatment.
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pain may be important for inclusion in pain education for patients
with pain following cancer treatment (i.e., to empower patients to
invest time in specific sleep interventions known to benefit sleep
problems in this population).
Cognitive behavioural therapy is effective, with large effect
sizes, for improving sleep in patients following cancer treat-
ment.[86] Such cognitive behavioural therapy for sleep typically
includes sleep hygiene and can be provided in face-to-face ses-
sions or using online programmes.[87] Such interventions are not
limited to a specific discipline but available for any therapist will-
ing to learn more about the role of sleep and how to improve it.
In addition to cognitive behavioural therapy for sleep difficulties,
stress management,[74] and exercise therapy [74,88] can also
improve sleep in patients following cancer treatment.
Exercise therapy
Exercise therapy has been shown to be effective for improving
quality of life in cancer survivors.[88–91] Systematic evaluation of
the effects of exercise on a multitude of cancer-related concerns,
e.g., fatigue, sleep, and mood reveals it is effective for these
impairments, but also shows some efficacy for decreasing pain in
this population.[88] Exercise therapy may be beneficial to cancer
survivors due to its positive effects on the cardiovascular system,
immune functioning, and musculoskeletal system, but may also
target central pain (inhibitory) mechanisms.[92] Given these bene-
fits, exercise may hold value for treatment of pain related side
effects of hormone treatments commonly used in cancer
survivors.[93]
Postmenopausal women with hormone receptor-positive breast
cancer receive hormone therapy as part of their (post-)cancer
treatment. One of the most frequently used and evidence-based
[94–96] hormone treatments are aromatase inhibitors (inhibitors
of the enzyme aromatase) that inhibit the conversion of andro-
gens to estrogens. This results in decreased availability of estro-
gens and slowed progression of breast cancer. Exercise/physical
activity also decreases the availability of estrogens in healthy
women.[97] Unfortunately, aromatase inhibitors often result in
debilitating side effects like pain: approximately 50% of breast
cancer survivors on aromatase inhibitor therapy report musculo-
skeletal pain.[98] Such musculoskeletal pain remains even after
stopping the hormone therapy.
The reason for this common side effect of aromatase inhibitors
is still an active area of research, and advances have been made.
Recent animal work suggests that aromatase inhibitors selectively
target the transient receptor potential ankyrin 1 (TRPA1) channel,
a major pathway in pain transmission, and neurogenic inflamma-
tion.[99] Aromatase inhibitors activate TRPA1 channels in nocicep-
tors, resulting in the release of sensory neuropeptides (i.e., neuro-
inflammation) and mechanical hypersensitivity, together corre-
sponding to a picture of generalized peripheral sensitization.
Indeed, TRPA1 is not only expressed on the distal, but also on the
central endings of the primary afferent nociceptive fibres, located
within the spinal dorsal horn.[100]
As pain is one of the main reasons for low-treatment adher-
ence and high-aromatase inhibitor discontinuation, combining
drug treatment with exercise therapy might overcome this prob-
lem. A high-quality randomized controlled trial showed that exer-
cise therapy (comprising a combination of aerobic and
strengthening exercise) is effective in decreasing aromatase inhibi-
tors-induced arthralgia in breast cancer survivors.[93] More specif-
ically, breast cancer survivors performed a home-based aerobic
exercise programme of 150min per week (walking or cycling) at
50–80% of maximal heart rate. The strength training included
supervised resistance training of lower and upper limb muscles
and was performed twice per week. The control group received
usual care and showed little pain severity changes throughout the
study period. The treatment group improved markedly in pain
severity and disability scores, with a mean improvement of 29% in
pain severity.[93] This number is most likely to reflect a clinically
important improvement, but given the capacity of the placebo
effect to generate large improvements in pain severity, a placebo-
controlled trial with similar treatment time for both arms is
required to confirm these findings.
Still, the positive effects of exercise therapy in patients follow-
ing cancer treatment [88–91] are not just limited to breast cancer
but also apply to head and neck cancer, brain, and spinal cord
cancer, myeloma, osteogenic cancers, and blood cancer, among
others. Another important consideration when prescribing exercise
is the presence of signs of central sensitization. The presence of
central sensitization may reduce the effectiveness of exercise
interventions. Although emerging evidence suggests a role for
central sensitization in explaining pain in a subgroup of patients
following cancer treatment,[31–33] evidence concerning the
effects of exercise therapy on pain processing in cancer survivors
is limited. To our knowledge, only two studies evaluated the effect
of exercise therapy on signs of central sensitization in cancer
patients. The first one found that widespread hypersensitivity in
patients following breast cancer treatment did not improve in
response to an 8-week water therapy exercise programme, even
though the number of myofascial trigger points decreased, and
the neck/shoulder/axillary pain improved.[101] The second study
demonstrated that hydrotherapy resulted in a significant increase
in pressure pain threshold levels of the affected and non-affected
side in breast cancer survivors with hormone therapy-associated
arthralgia.[102] More studies examining whether exercise therapy
is capable of decreasing hypersensitivity of the nervous system in
patients following cancer treatment are needed, including studies
using exercise therapy adopted to our current understanding of
pain neuroscience.[103,104] Further, research is warranted to
investigate both the presence of central sensitization in this
group, and whether exercise can help to improve pain in this
scenario.
Conclusions
Pain neuroscience and neuro-immunology has increased our
understanding of pain following cancer treatment, but the latter
stays an underestimated clinical problem in a fast growing popu-
lation. It is time to implement contemporary pain neuroscience to
care for patients with pain following cancer and cancer treatment.
Rehabilitation clinicians are perfectly situated within the health
care system to implement contemporary pain neuroscience and
neuro-immunology in this population.
First, pain education is a potentially effective but underused
strategy for treating cancer related pain.[40] When providing pain
education to patients following cancer treatment, implementation
of contemporary pain neuroscience into the educational pro-
gramme seems warranted for yielding positive effects on interfer-
ence with daily activities. When doing so, rehabilitation clinicians
are advised to take into account that pain in cancer survivors is
contextualized by the serious condition that has been a precursor
for pain. In many cases, the pain experienced by these patients
has often, at least initially, been associated with real damage and
danger and, therefore, has potentially a higher threat value com-
pared to other (chronic) pain populations. Secondly, in this popu-
lation, there is often a constant fear for recurrence, so it might be
harder to reconceptualize the pain as an unreliable and harmless
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signal. Therefore, it is very important for both patient and therap-
ist to be confident/reassured about that issue. Finally, it is possible
that cancer survivors are less admissive about their pain, due to
the enormous psychological burden caused by the disease.
Second, some patients following cancer treatment show a sub-
tle hypothalamus-pituitary adrenal axis dysfunction and decreased
vagal activity.[51–55] Our neuro-immunological understanding of
how stress can influence pain highlights the importance of inte-
grating stress management into the treatment approach for
patients having pain following cancer, a notion underscored by
the available evidence supporting the use of various stress man-
agement programmes for this population of survivors.[66–69]
Third, poor sleep is common [74–77] and linked to pain
[74,76,78] in patients following cancer treatment. Sleep depriv-
ation imparts a low-grade inflammatory response possibly leading
towards increased sensitivity to pain as typically seen in chronic
pain sufferers. Cognitive behavioural therapy for sleep difficul-
ties,[86,87] stress management,[74] and exercise therapy [74,88]
improves sleep in patients following cancer treatment. Finally,
exercise therapy is effective for decreasing pain in patients follow-
ing cancer treatment,[88] and may even decrease pain-related
side effects of hormone treatments commonly used in cancer sur-
vivors.[93] More studies examining whether exercise therapy is
capable of decreasing the hypersensitivity of the nervous system
in a subgroup of patients with predominant central sensitization
pain in patients following cancer treatment [32,33] are emerging.
Likewise, there is a need for studies examining the role of pain in
explaining quality of life after stopping all cancer treatment, espe-
cially given the increasing survivorship time. Will rehabilitation
clinicians take the lead in implementing and researching pain
neuroscience in people following cancer treatment like they did in
the area of musculoskeletal pain, taking into account the specific
profile of these people?
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